Super-Selective Intraarterial Cerebral Infusion of Cetuximab (Erbitux) for Treatment of Relapsed/Refractory GBM and AA

NCT01238237 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma Multiforme (GBM)
ANAPLASTIC ASTROCYTOMA (AOA)
GBM
Anaplastic Astrocytoma

Interventions

DRUG: Superselective Intraarterial Cerebral Infusion of Cetuximab

Sponsor

Northwell Health